Moderna falls on reports FDA official Peter Marks resigns
ReutersMar 31, 2025 11:26 AM
** Shares of vaccine maker Moderna MRNA.O fall 13.8% to $26.9 premarket
** The Wall Street Journal and other media outlets reported on Friday that Peter Marks, a top vaccine official at the U.S. FDA, has been pushed out of the agency
** Marks played a key role in U.S. President Donald Trump's first term in developing COVID-19 vaccines
** Marks was given the choice by a Health and Human Services official to resign or be fired, according to WSJ, which also reported that his resignation is effective April 5
** As of last close, MRNA has fallen 71% in past 12 months
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
U.S. March Nonfarm Payroll Preview: Even If Data Aligns with Expectations, Financial Markets May Not Escape the Fate of Volatility
On 4 April 2025, the United States will release its March Nonfarm Payrolls (NFP) data. The market consensus currently anticipates job growth of 128,000, a decline from February’s 151,000. We align with this prevailing forecast.TradingKey
20 hours ago
2025 S&P 500 Forecasts on Wall Street: Why Are Analysts Divided?
TradingKey - Wall Street's forecasts for the S&P 500 index in 2025 show a rare split: the lowest target from Stifel stands at 5,500 points, while Oppenheimer's highest target is 7,100 points, marking a significant 20% disparity. This is the biggest difference in annual outlooks among investment bankTradingKey
Fri, Mar 28
Ray Dalio’s Warning on “Unsustainable” US Debt: What Investors Need to Know
Tradingkey - So far in 2025, it has been a roller coaster ride for investors. The rally in US stock markets post-President Trump’s election quickly fizzled out as markets realised he was serious about imposing punitive tariffs on both allies and strategic competitors.TradingKey
Thu, Mar 27
